Early immunization with conjugate vaccines

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1433-1438

  Eskola, Juhani ^a   Käyhty, Helena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Conjugate vaccines; Haemophilus influenzae; Neonatal vaccination

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBODY RESPONSE; CONFERENCE PAPER; DRUG SAFETY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; NEWBORN; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS INFECTION;

HAEMOPHILUS VACCINES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; POLYSACCHARIDES, BACTERIAL; VACCINATION; VACCINES, CONJUGATE;

EID: 0032147056     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00104-2     Document Type: Conference Paper

References (30)

1. 1 Bijlmer, H.A. Epidemiology of Haemophilus influenzae invasive disease in developing countries and intervention strategies. In: Development and Uses of Haemophilus b Conjugate Vaccines (Eds Ellis, R.W. and Granoff, D.M.). Marcel Dekker, New York, 1994, pp. 247-264
2. 2 Claesson, B.A., Schneerson, R. and Robbins, J.B. et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide tetanus toxoid conjugate. J. Pediatr. 1989, 114, 97-100
3. 3 Halsey, N.A. and Klein, D. Maternal immunization. Pediatr. Infect. Dis. J. 1990, 9, 574-581
4. 4 Sarvas, H., Kurikka, S., Seppälä, I.J.T., Mäkelä, P.H. and Mäkelä, O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J. Infect. Dis. 1992, 165, 977-979
5. 5 Barington, T., Gyhrs, A., Kristensen, K. and Heilman, C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infection and Immunity 1994, 62, 9-14
6. 6 Kurikka, S., Ölander, R.-M., Eskola, J. and Käyhty, H. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr. Infect. Dis. J. 1996, 15, 530-535
7. 7 Siegrist, C.A. and Lambert, P.M. Maternal immunity and infant responses to immunization: factors influencing infant responses. Developments in Biological Standardization (in press)
8. 8 Fisher, G.W., Ottolini, M.G. and Mond, J.J. Prospects for vaccines during pregnancy and in the newborn period. Clinics in Perinatology 1997, 24, 231-249
9. 9 Ward, J.I., Bulkow, L., Wainwright, R. and Chang, S. Immune tolerance and lack of booster responses to Haemophilus influenzae (Hib) conjugate vaccination in infants immunized beginning at birth. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Anaheim, Calif., 1992. Abstract # 984
10. 10 Lieberman, J.M., Greenberg, D.P. and Wong, V.K. et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J. Pediatr. 1995, 126, 198-205
11. 11 Kurikka, S., Käyhty, H., Peltola, H., Saarinen, L., Eskola, J. and Mäkelä, P.H. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics 1995, 95, 815-822
12. 12 Munoz, A., Salvador, A., Brodsky, N.L., Arbeter, A.M. and Porat, R. Antibody response of low birth weight infants to Haemophilus influenzae type b polyriposylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995, 96, 216-219
13. 13 D'Angio, C.T., Maniscalco, W.M. and Pichichero, M.E. Immunologie response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995, 96, 18-22
14. 14 Kurikka, S., Käyhty, H., Saarinen, L, Rönnberg, P.-R., Eskola, J. and Mäkelä, P.H. Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. J. Pediatr. 1996, 128, 524-530
15. 15 Sarvas, H., Seppälä, I., Kurikka, S., Siegberg, R. and Mäkelä, O. Half-life of the maternal IgG allotype in infants. J. Clin. Immunol. 1993, 13, 145-151
16. 16 Sorva, R., Tolppanen, E.M. and Perheentupa, J. Variation of growth in length and weight of children. I: years 1 and 2. Acta Paediatr. Scand. 1990, 79, 490-497
17. 17 Madore, D.V., Johnson, C.L. and Phipps, D.C. et al. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1-to 6-month-old infants. Pediatrics 1990, 85, 331-337
18. 18 Mulholland, E.K., Byass, P. and Campbell, H. et al. The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants. Ann. Trop. Paediatr. 1994, 14, 183-188
19. 19 Capeding, R.Z., Nohynek, H. and Pasqual, L.G. et al. The immunogenicity of three Haemophilus influenzae type b conjugate vaccines after a primary vaccination series in Philippine infants. Am. J. Trop. Med. Hyg. 1996, 55, 516-520
20. 20 Washburn, L.K., O'Shea, T.M., Gillis, D.C., Block, S.M. and Abramson, J.S. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J. Pediatr. 1993, 123, 791-794
21. 21 Greenberg, D.P., Vadheim, C.M., Prtridge, S., Chang, S.-J., Chiu, C.-Y., Ward, J.I. and the Kaiser-UCLA Vaccine Study Group, Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. J. Infect. Dis. 1994, 170, 76-81
22. 22 Kristensen, K., Gyhrs, A., Lausen, B., Barington, T. and Heilman, C. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr. Infect. Dis. J. 1996, 15, 525-529
23. 23 Siber, G.R., Thompson, C. and Reid, G.R. et al. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J. Infect. Dis. 1992, 165, S129-S133
24. 24 Käyhty, H., Peltola, H., Karanko, V. and Mäkelä, P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 1983, 147, 1100
25. 25 Eskola, J., Käyhty, H. and Takala, A.K. et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children agaist invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 1990, 323, 1381-1387
26. 26 Granoff, D.M., Holmes, S.J. and Osterholm, M.T. et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J. Infect. Dis. 1993, 168, 663-671
27. 27 Käyhty, H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae type b conjugate vaccines. Biologicals 1994, 22, 397-402
28. 28 Kurikka, S., Käyhty, H., Saarinen, L., Rönnberg, P.-R., Eskola, J. and Mäkelä, P.H. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J. Infect. Dis. 1995, 172, 1268-1272
29. 29 Peltola, H., Käyhty, H., Virtanen, M. and Mäkelä, P.H. Prevention of Haemophilus influenzae type b bacteremic infections with the polysaccharide vaccine. N. Engl. J. Med. 1984, 310, 1566-1569
30. 30 Mosier, D.E., Freeney, A.J. and Shcerle, P. The physiology of B lymphocytes capable of generating anti-polysaccharide antibody responses. In: Towards Better Carbohydrate Vaccines (Eds Bell, R. and Torrigiani, G.). Wiley, Chichester, 1987, pp. 243-261